Eudaimonia Partners’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.23M Sell
2,570
-9
-0.3% -$4.14K 0.29% 78
2023
Q4
$1.21M Buy
+2,579
New +$1.21M 0.32% 70
2023
Q3
Sell
-2,599
Closed -$1.18M 346
2023
Q2
$1.18M Buy
2,599
+1
+0% +$454 0.27% 94
2023
Q1
$1.2M Hold
2,598
0.29% 89
2022
Q4
$1.42M Buy
2,598
+4
+0.2% +$2.09K 0.35% 73
2022
Q3
$1.22M Sell
2,594
-544
-17% -$259K 0.32% 82
2022
Q2
$1.5M Buy
3,138
+27
+0.9% +$12.4K 0.28% 97
2022
Q1
$1.39M Buy
+3,111
New +$1.28M 0.24% 112
2021
Q3
$1.1M Sell
3,069
-131
-4% -$47.3K 0.2% 138
2021
Q2
$1.16M Sell
3,200
-296
-8% -$107K 0.22% 123
2021
Q1
$1.13M Sell
3,496
-65
-2% -$19.6K 0.24% 104
2020
Q4
$1.08M Sell
3,561
-41
-1% -$12.5K 0.24% 101
2020
Q3
$1.14M Buy
3,602
+240
+7% +$78.2K 0.29% 87
2020
Q2
$1.03M Sell
3,362
-50
-1% -$16.4K 0.39% 65
2020
Q1
$1.03M Buy
3,412
+21
+0.6% +$7.3K 0.45% 57
2019
Q4
$1.17M Buy
+3,391
New +$1.19M 0.46% 58

Other funds holding NOC

Eudaimonia Partners's NOC Position: Q1 2024 in Review

Eudaimonia Partners reduced its Northrop Grumman (NOC) stake by 0.35% in Q1 2024, selling an estimated $4.14K and leaving 2,570 shares worth $1.23M. The position accounts for 0.29% of the portfolio, ranked #78.

Eudaimonia Partners first reported a position in NOC in Q4 2019 and has held it in 16 quarters since. The position peaked at $1.5M in Q2 2022. 1,513 funds tracked by Wall St. Rank hold NOC as of Q1 2024.

  • Eudaimonia Partners held 2,570 shares of Northrop Grumman worth $1.23M as of Q1 2024.
  • Eudaimonia Partners sold 9 Northrop Grumman shares in Q1 2024, an estimated $4.14K.
  • Northrop Grumman made up 0.29% of Eudaimonia Partners's portfolio in Q1 2024, its #78 holding.
  • Eudaimonia Partners first reported a position in Northrop Grumman in Q4 2019 and has held it in 16 quarters since.
  • Eudaimonia Partners's Northrop Grumman position peaked at $1.5M in Q2 2022.
  • 1,513 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.